Evidence map›Paper›PMID 26411347›Full record

ArticleVeterinary research2015

Immunization routes in cattle impact the levels and neutralizing capacity of antibodies induced against S. aureus immune evasion proteins.

Eveline Boerhout, Manouk Vrieling, Lindert Benedictus, Ineke Daemen, Lars Ravesloot, Victor Rutten, Piet Nuijten, Jos van Strijp, Ad Koets, Susanne Eisenberg

Open access · goldAbstract read
In one paragraph

Article in Veterinary research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Eveline BoerhoutRuminant Research and Development, MSD Animal Health, Wim de Körverstraat 35, 5830, AA, Boxmeer, The Netherlands. eveline.boerhout@merck.com.
Manouk VrielingDepartment of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584, CL, Utrecht, The Netherlands. m.vrieling@uu.nl.
Lindert BenedictusDepartment of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584, CL, Utrecht, The Netherlands. l.benedictus1@uu.nl.
Ineke DaemenDepartment of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584, CL, Utrecht, The Netherlands. a.j.j.m.daemen@uu.nl.
Lars RaveslootDepartment of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584, CL, Utrecht, The Netherlands. l.ravesloot@uu.nl.
Victor RuttenDepartment of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584, CL, Utrecht, The Netherlands. v.rutten@uu.nl.
Piet NuijtenRuminant Research and Development, MSD Animal Health, Wim de Körverstraat 35, 5830, AA, Boxmeer, The Netherlands. piet.nuijten@merck.com.
Jos van StrijpDepartment of Medical Microbiology, University Medical Center Utrecht, PO G04.614, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. j.vanstrijp@umcutrecht.nl.
Ad KoetsDepartment of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584, CL, Utrecht, The Netherlands. a.p.koets@uu.nl.
Susanne EisenbergDepartment of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584, CL, Utrecht, The Netherlands. s.w.f.eisenberg@uu.nl.
Utrecht University · NLMSD (Netherlands) · NLHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines against S. aureus bovine mastitis are scarce and show limited protection only. All currently available vaccines are applied via the parenteral (usually intramuscular) route. It is unknown, however, whether this route is the most suitable to specifically increase intramammary immunity to combat S. aureus at the site of infection. Hence, in the present study, immunization via mucosal (intranasal; IN), intramuscular (triangle of the neck; IM), intramammary (IMM) and subcutaneous (suspensory ligament; SC) routes were analyzed for their effects on the quantity of the antibody responses in serum and milk as well as the neutralizing capacity of the antibodies within serum. The experimental vaccine comprised the recombinant S. aureus immune evasion proteins extracellular fibrinogen-binding protein (Efb) and the leukotoxin subunit LukM in an oil-in-water adjuvant combined with a hydrogel and alginate. The highest titer increases for both Efb and LukM specific IgG1 and IgG2 antibody levels in serum and milk were observed following SC/SC immunizations. Furthermore, the harmful effects of Efb and leukotoxin LukMF' on host-defense were neutralized by serum antibodies in a route-dependent manner. SC/SC immunization resulted in a significant increase in the neutralizing capacity of serum antibodies towards Efb and LukMF', shown by increased phagocytosis of S. aureus and increased viability of bovine leukocytes. Therefore, a SC immunization route should be considered when aiming to optimize humoral immunity against S. aureus mastitis in cattle.

Indexed as

AnimalsAntibodies, BacterialBacterial ProteinsCattleCattle DiseasesFemaleImmunizationMastitis, BovineMilkStaphylococcal InfectionsStaphylococcal VaccinesStaphylococcus aureusVaccines, SyntheticAntibodies, BacterialBacterial ProteinsEfb protein, Staphylococcus aureusLukM protein, Staphylococcus aureusStaphylococcal VaccinesVaccines, Synthetic

Identifiers

PMID26411347
PMCPMC4584483
OpenAlexW2156586940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.